Literature DB >> 22125933

The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.

Jasmin Burgos1, Eduardo de la Cruz, Rose Paredes, Cora Revelyn Andaya, Robert H Gelber.   

Abstract

INTRODUCTION: Moxifloxacin, rifampicin, rifapentine, linezolid, and PA 824, alone and in combination, have been previously administered, as single doses and five times daily doses, to M. leprae infected mice during lag phase multiplication and were each found to have some bactericidal activity.
DESIGN: The fluroquinolones, ofloxacin, moxifloxacin and gatifloxacin, (50 mg/kg, 150 mg/kg and 300 mg/kg) and the rifamycins (5 mg/kg, 10 mg/kg, and 20 mg/kg), rifampicin and rifapentine, were evaluated alone and in combination for bactericidal activity against M. leprae using the mouse footpad model during logarithmic multiplication. Linezolid and PA 824 were similarly evaluated alone and linezolid in combination with rifampicin, minocycline and ofloxacin.
RESULTS: The three fluroquinolones and rifamycins were found alone and in combination to be bactericidal at all dosage schedules. PA 824 had no activity against M. leprae, while linezolid at a dose of 25 mg/kg was bacteriostatic, and progressively more bactericidal at doses of 50 mg/kg and 100 mg/kg. No antagonisms were detected between any of these drugs when used in combinations.
CONCLUSION: Moxifloxacin, gatifloxacin, rifapentine and linezolid were found bactericidal against rapidly multiplying M. leprae.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125933

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  4 in total

Review 1.  Current approaches and future directions in the treatment of leprosy.

Authors:  Sophie M Worobec
Journal:  Res Rep Trop Med       Date:  2012-08-01

2.  Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.

Authors:  Grace L Davis; Nashone A Ray; Ramanuj Lahiri; Thomas P Gillis; James L Krahenbuhl; Diana L Williams; Linda B Adams
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

Review 3.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27

4.  Nitazoxanide is active against Mycobacterium leprae.

Authors:  Mai Ann Bailey; Hana Na; Malcolm S Duthie; Thomas P Gillis; Ramanuj Lahiri; Tanya Parish
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.